Health
Convalescent plasma fails to improve outcome of COVID-19 in India – News-Medical.Net
A new study based in India and published on the medRxiv preprint server explores the role of convalescent plasma (CP) in the treatment of moderate COVID-19 within the limitations on resources faced in a developing country.
The COVID-19 pandemic is still raging in India, with over 4.37 million cases and almost 90,000 new cases a day at present. There are few effective therapeutic options, which means that healthcare providers are faced with ongoing challenges in managing the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A new study based in India and published on the medRxiv* preprint server explores the role of convalescent plasma (CP) in the treatment of moderate COVID-19 within the limitations on…
-
Noosa News19 hours agoPolice officer who tracked Toyah Cordingley’s phone gives evidence at Rajwinder Singh’s murder trial
-
General18 hours agoARIA Awards 2025 winners: Amyl & The Sniffers and Ninajirachi dominate
-
Noosa News17 hours agoMurray Watt claims Queensland will follow Sussan Ley and ditch net zero by 2050
-
General16 hours agoRussian barrage kills 25 in Ukraine city as Zelenskyy holds talks with Turkish leader
